Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) ACTB → ATF2 |
| (<<) B3GNT2 → ATF2 |
| (<<) BZW1 → ATF2 |
| (<<) CASP2 → ATF2 |
| (<<) CDK8 → ATF2 |
| (<<) CRK → ATF2 |
| (<<) CRKL → ATF2 |
| (<<) ITGB1 → ATF2 |
| (<<) MAP3K2 → ATF2 |
| (<<) MAP3K7 → ATF2 |
| (<<) MAPK14 → ATF2 |
| (<<) PTPN12 → ATF2 |
| (<<) RAB5A → ATF2 |
| (<<) RRAS2 → ATF2 |
| (<<) RXRB → ATF2 |
| (<<) RYK → ATF2 |
| (<<) YWHAE → ATF2 |
| (<<) YWHAZ → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → CASP8 (>>) |
| ATF2 → FZD10 (>>) |
| ATF2 → GNA13 (>>) |
| ATF2 → ITGA6 (>>) |
| ATF2 → MAP3K1 (>>) |
| ATF2 → MEX3B (>>) |
| ATF2 → NET1 (>>) |
| ATF2 → NRAS (>>) |
| ATF2 → PAK2 (>>) |
| ATF2 → PLA2G3 (>>) |
| ATF2 → RDX (>>) |
| ATF2 → SOS2 (>>) |
| ATF2 → TP53 (>>) |
| ATF2 → TSPAN10 (>>) |
